The modern pharmacopoeia: a return to depressive realism?

Bipolar Disord. 2008 Dec;10(8):969-72. doi: 10.1111/j.1399-5618.2008.00632.x.
No abstract available

Publication types

  • Comment
  • Comparative Study

MeSH terms

  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / therapeutic use*
  • Antidepressive Agents, Second-Generation / adverse effects
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Bipolar Disorder / chemically induced
  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / drug therapy*
  • Bipolar Disorder / psychology
  • Chronic Disease
  • Depressive Disorder / diagnosis
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / psychology
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / psychology
  • Drug Resistance
  • Drug Therapy, Combination
  • Humans
  • Long-Term Care
  • Randomized Controlled Trials as Topic
  • Risk Factors
  • Secondary Prevention
  • Treatment Outcome

Substances

  • Antidepressive Agents
  • Antidepressive Agents, Second-Generation